BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/6/2020 2:43:56 PM | Browse: 830 | Download: 1500
 |
Received |
|
2020-02-06 09:57 |
|
Peer-Review Started |
|
2020-02-06 09:57 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-03-21 23:04 |
|
Revised |
|
2020-05-08 07:37 |
|
Second Decision |
|
2020-05-22 10:36 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-05-23 01:01 |
|
Articles in Press |
|
2020-05-23 01:01 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-06-03 08:15 |
|
Publish the Manuscript Online |
|
2020-06-06 14:43 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Niels Teich, Harald Grümmer, Eric Jörgensen, Thomas Liceni, Frank Holtkamp-Endemann, Tim Fischer and Susanne Hohenberger |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| MSD Sharp and Dohme GmbH, Haar, Germany |
|
|
| Corresponding Author |
Niels Teich, MD, Doctor, Internistische Gemeinschaftspraxis für Verdauungs-und Stoffwechselkrankheiten Leipzig und Schkeuditz, Nordstr. 21, Leipzig 04105, Germany. teich@igvs.de |
| Key Words |
Ulcerative colitis; Quality of life; Work productivity; Non-interventional study; Golimumab; Work Productivity Activity Impairment Questionnaire |
| Core Tip |
Systematic reviews indicate that ulcerative colitis (UC) causes a significant socioeconomic burden, but prospective studies are scarce. The aim of this study is to evaluate the changes in work productivity and quality of life (QoL) of UC patients in Germany treated with the human monoclonal tumor necrosis factor alpha antibody golimumab in order to assess the specific benefit of this treatment option. This prospective non-interventional study included 287 patients. Based on these data we were able to show that treatment of moderate-to-severe UC with golimumab leads to significant improvements in patient´s work productivity, daily activity and QoL over twelve months. |
| Publish Date |
2020-06-06 14:43 |
| Citation |
Teich N, Grümmer H, Jörgensen E, Liceni T, Holtkamp-Endemann F, Fischer T, Hohenberger S. Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results. World J Gastroenterol 2020; 26(21): 2852-2563 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i21/2852.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i21.2852 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
